● Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Condition: Breast Cancer · Sponsor: Stemline Therapeutics, Inc.

PhasePhase 3

Planned participants4220

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.

This description comes directly from the study's public registry record.

Talk to the study team

Stemline Trials · 1-877-332-7961 · clinicaltrials@menarinistemline.com

Always discuss trial participation with your own doctor first.

Locations (555)

Southern Cancer Center, PC	Daphne, Alabama, United States	Recruiting
Ironwood Cancer and Research Centers	Chandler, Arizona, United States	Recruiting
Banner MD Anderson Cancer Center	Gilbert, Arizona, United States	Recruiting
Mayo Clinic	Scottsdale, Arizona, United States	Recruiting
Arizona Clinical Research Center, Inc.	Tucson, Arizona, United States	Recruiting
University of Arizona Cancer Center	Tucson, Arizona, United States	Recruiting
Highlands Oncology Group, PA	Springdale, Arkansas, United States	Recruiting
Comprehensive Blood & Cancer Center	Bakersfield, California, United States	Recruiting
UCSF Cancer Center Berkeley	Berkeley, California, United States	Recruiting
Cedars-Sinai Cancer Beverly Hills	Beverly Hills, California, United States	Recruiting
City of Hope National Medical Center	Duarte, California, United States	Recruiting
UCSF Wash Cancer CNTR	Fremont, California, United States	Recruiting

+ 543 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06492616